PHARMACIELO LTD (PCLO.CA) Stock Cash Flow
TSX-V:PCLO - TSX Venture Exchange - CA71716K1012 - Common Stock - Currency: CAD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.30M | -14.52M | -26.63M | -43.76M | -34.67M | |||
| Depreciation Amortization | 1.41M | 1.58M | 1.26M | 1.57M | 1.28M | |||
| Change In Working Capital | 2.22M | -1.79M | -7.58M | 3.31M | -4.65M | |||
| Other non cash items | 7.52M | 4.85M | 12.88M | 16.32M | 12.87M | |||
| OPERATING CASH FLOW | -5.15M | -9.88M | -20.07M | -22.56M | -25.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -15.30K | -521.90K | -1.14M | -5.43M | -11.45M | |||
| Other Investing Activity | 406.90K | -36.50K | -519.10K | -138.00K | 184.30K | |||
| INVESTING CASH FLOW | 391.60K | -558.30K | -1.66M | -5.57M | -11.27M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.63M | 5.17M | 4.61M | 2.89M | -261.50K | |||
| Stock Issued/Repurchased | N/A | 83.20K | 14.87M | 22.32M | 5.35M | |||
| Other Financing Activity | N/A | 40.00K | -1.28M | -1.89M | -577.30K | |||
| FINANCING CASH FLOW | 4.63M | 5.30M | 18.21M | 23.32M | 4.51M | |||
| Exchange Rate Effect | 19.10K | -28.10K | N/A | N/A | -80.80K | |||
| CHANGE IN CASH | -110.80K | -5.17M | -3.52M | -4.81M | -32.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.15M | -9.88M | -20.07M | -22.56M | -25.16M | |||
| Capital Expenditure | -15.30K | -521.90K | -1.14M | -5.43M | -11.45M | |||
| FREE CASH FLOW | -5.17M | -10.40M | -21.21M | -28.00M | -36.62M | |||
All data in CAD